The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
Open accessAbstract
Background Intensive treatment of multiple cardiovascular risk factors can halve mortality among people with established type 2 diabetes. We investigated the effect of early multifactorial treatment after diagnosis by screening.Methods In a pragmatic, cluster-randomised, parallel-group trial done in Denmark, the Netherlands, and the UK, 343 general practices were randomly assigned screening of registered patients aged 40-69 years without known diabetes followed by routine care of diabetes or screening followed by intensive treatment of multiple risk factors. The primary endpoint was first cardiovascular event, including cardiovascular mortality and morbidity, revascularisation, and non-traumatic amputation within 5 years. Patients and staff assessing outcomes were unaware of the practice's study group assignment. Analysis was done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00237549.Findings Primary endpoint data were available for 3055 (99·9%) of 3057 screen-detected patients. The mean age was 60·3 (SD 6·9) years and the mean duration of follow-up was 5·3 (SD 1·6) years. Improvements in cardiovascular risk factors (HbA(1c) and cholesterol concentrations and blood pressure) were slightly but significantly better in the intensive treatment group. The incidence of first cardiovascular event was 7·2% (13·5 per 1000 person-years) in the intensive treatment group and 8·5% (15·9 per 1000 person-years) in the routine care group (hazard ratio 0·83, 95% CI 0·65-1·05), and of all-cause mortality 6·2% (11·6 per 1000 person-years) and 6·7% (12·5 per 1000 person-years; 0·91, 0·69-1·21), respectively.Interpretation An intervention to promote early intensive management of patients with type 2 diabetes was associated with a small, non-significant reduction in the incidence of cardiovascular events and death.Funding National Health Service Denmark, Danish Council for Strategic Research, Danish Research Foundation for General Practice, Danish Centre for Evaluation and Health Technology Assessment, Danish National Board of Health, Danish Medical Research Council, Aarhus University Research Foundation, Wellcome Trust, UK Medical Research Council, UK NIHR Health Technology Assessment Programme, UK National Health Service R&D, UK National Institute for Health Research, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, Novo Nordisk, Astra, Pfizer, GlaxoSmithKline, Servier, HemoCue, Merck.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ADDITION (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care) trial showed that microvascular or macrovascular events were not significantly reduced after 5 or 10 years (17% and 13% reduction, respectively), while intervention only slightly improved HbA1c.364,365”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [365]
In the citing paper
“These positive effects were not observed in the clinical intervention trials of intensified, multifactorial treatment for T2DM in primary care and early in the disease trajectory.”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [365]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Research works printed but not linked: 2
- Rutten, 1999, Dutch College of General Practitioners. Practice guideline diabetes mellitus type 2, Huisarts Wetensch, 42, 67
- Rutten, 2006, Dutch Guidelines on Type 2 Diabetes Mellitus. Dutch College of General Practitioners, Huisarts Wetensch, 49, 137
Cited by
Sorted by citations
Items 101–200 of 462
Dela, F., Ingersen, A., Andersen, N. B., Nielsen, M. B., Petersen, H. H. H., HANSEN, C. N., Larsen, S., Wojtaszewski, J. F. P., & Helge, J. W. (2018) · Acta Physiologica · doi:10.1111/apha.13245 · Cited by 54
Bain, S. C., Hansen, B. B., Malkin, S. J. P., Nuhoho, S., Valentine, W. J., Chubb, B., Hunt, B., & Capehorn, M. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00736-6 · Cited by 57
Simmons, R. K., Griffin, S. J., Witte, D. R., Borch-Johnsen, K., Lauritzen, T., & Sandbæk, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4323-2 · Cited by 51
Self-citationAquino, J. A., Baldoni, N. R., Flôr, C. R., Sanches, C., Di Lorenzo Oliveira, C., Alves, G. C. S., Fabbro, A. L. D., & Baldoni, A. O. (2018) · Primary Care Diabetes · doi:10.1016/j.pcd.2017.10.004 · Cited by 51
Long, G. H., Cooper, A., Wareham, N. J., Griffin, S. J., & Simmons, R. K. (2014) · Diabetes Care · doi:10.2337/dc13-1731 · Cited by 51
Self-citationValidation of the UKPDS 82 risk equations within the Cardiff Diabetes Model
McEwan, P., Ward, T. T., Bennett, H., & Bergenheim, K. (2015) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-015-0038-8 · Cited by 49
Bakke, Å., Cooper, J. G., Thue, G., Skeie, S., Carlsen, S., Dalen, I., Løvaas, K. F., Madsen, T. V., Oord, E. R., Berg, T. J., et al. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000459 · Cited by 49
Geneviève, L. D., Martani, A., Mallet, M. C., Wangmo, T., & Elger, B. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226015 · Cited by 54
Sattar, N. A. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03480.x · Cited by 50
Jørgensen, M. E., Ellervik, C., Ekholm, O., Johansen, N. B., & Carstensen, B. (2018) · Scandinavian Journal of Public Health · doi:10.1177/1403494818799606 · Cited by 49
Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.02.002 · Cited by 60
Self-citationHyperglycemia and Vascular Metabolic Memory: Truth or Fiction?
Bianchi, C., Miccoli, R., & Prato, S. D. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0371-2 · Cited by 47
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT
Griffin, S. J., Bethel, M. A., Holman, R. R., Khunti, K., Wareham, N. J., Brierley, G., Davies, M. J., Dymond, A., Eichenberger, R., Evans, P. H., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22180 · Cited by 50
Self-citationWermeling, P. R., Gorter, K. J., van Stel, H. F., & Rutten, G. E. H. M. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-121 · Cited by 50
Self-citationHansen, L. J., Siersma, V., Beck‐Nielsen, H., & Olivarius, N. D. F. (2013) · Diabetologia · doi:10.1007/s00125-013-2893-1 · Cited by 46
Diabetes Screening Among Immigrants
Creatore, M. I., Booth, G. L., Manuel, D. G., Moineddin, R., & Glazier, R. H. (2012) · Diabetes Care · doi:10.2337/dc11-1393 · Cited by 46
Inzucchi, S. E., Khunti, K., FITCHETT, D. H., Wanner, C., Mattheus, M., George, J. T., Ofstad, A. P., & Zinman, B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa321 · Cited by 47
Self-citationViljoen, A., Hoxer, C. S., Johansen, P., Malkin, S., Hunt, B., & Bain, S. C. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13564 · Cited by 45
Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.05.004 · Cited by 46
Self-citationKonnyu, K. J., Yogasingam, S., Lépine, J., Sullivan, K., Alabousi, M., Edwards, A. L., Hillmer, M. P., Karunananthan, S., Lavis, J. N., Linklater, S., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014513 · Cited by 46
Seidu, S., Achana, F. A., Gray, L. J., Davies, M. J., & Khunti, K. (2015) · Diabetic Medicine · doi:10.1111/dme.12885 · Cited by 44
Self-citationCunningham-Myrie, C. A., Younger-Coleman, N. O., Tulloch-Reid, M. K., McFarlane, S., Francis, D., Ferguson, T. S., Gordon-Strachan, G. M., & Wilks, R. (2013) · Tropical Medicine & International Health · doi:10.1111/tmi.12190 · Cited by 44
Tanaka, A., Inoue, T., Kitakaze, M., Oyama, J.-I., Sata, M., Taguchi, I., Shimizu, W., Watada, H., Tomiyama, H., Ako, J., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0381-x · Cited by 41
Hansen, C. S., Jensen, T. M., Jensen, J. S., Nawroth, P. P., Fleming, T. H., Witte, D. R., Lauritzen, T., Sandbaek, A., Charles, M., Fleischer, J., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12753 · Cited by 43
Self-citationRisk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark
Andersen, S. T., Witte, D. R., Andersen, H., Bjerg, L., Bruun, N. H., Jørgensen, M. E., Finnerup, N. B., Lauritzen, T., Jensen, T. S., Tankişi, H., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0392 · Cited by 38
Self-citationHammoud, S. H., AlZaim, I., Mougharbil, N., Koubar, S. H., Eid, A. H., Eid, A. A., & EL‐Yazbi, A. F. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114491 · Cited by 39
Gray, L. J., Khunti, K., Edwardson, C. L., Goldby, S., Henson, J. J., Morris, D. H., Sheppard, D., Webb, D. R., Williams, S. T., Yates, T. E., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2725-8 · Cited by 38
Self-citationPrevention of microalbuminuria in patients with type 2 diabetes and hypertension
Menne, J., Izzo, J. L., Ito, S., Januszewicz, A., Katayama, S., Chatzykirkou, C., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328351856d · Cited by 37
Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes
den Ouden, H., Pellis, L., Rutten, G. E. H. M., van Vonderen, I. K., Rubingh, C. M., van Ommen, B., van Erk, M. J., & Beulens, J. W. J. (2016) · Metabolomics · doi:10.1007/s11306-015-0930-4 · Cited by 37
Self-citationAdvanced Techniques for Predicting the Future Progression of Type 2 Diabetes
Islam, M. S., Qaraqe, M., Belhouari, S. B., & Abdul‐Ghani, M. A. (2020) · IEEE Access · doi:10.1109/access.2020.3005540 · Cited by 37
Basu, S., Millett, C. J., Vijan, S. S., Hayward, R. A., Kinra, S., Ahuja, R., & Yudkin, J. S. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001827 · Cited by 36
Screening with urinary dipsticks for reducing morbidity and mortality
Krogsbøll, L. T., Jørgensen, K. J., & Gøtzsche, P. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010007.pub2 · Cited by 36
Screening for hyperglycemia in the developing world: Rationale, challenges and opportunities
Echouffo-Tcheugui, J. B., Mayige, M. T., Ogbera, A. O., Sobngwi, E., & Kengne, A. P. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.003 · Cited by 35
The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study
Gillett, M., Brennan, A., Watson, P., Khunti, K., Davies, M. J., Mostafa, S. A., & Gray, L. J. (2015) · Health Technology Assessment · doi:10.3310/hta19330 · Cited by 37
Self-citationUeki, K., Sasako, T., Kato, M., Okazaki, Y., Okahata, S., Katsuyama, H., Haraguchi, M., Morita, A., Ohashi, K., Hara, K., et al. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000123 · Cited by 35
Määttä, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Kühle, J., Tankişi, H., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2208 · Cited by 34
Narayan, K. M. V., Echouffo-Tcheugui, J. B., Mohan, V., & Ali, M. K. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1040 · Cited by 35
Self-Reported Prevalence of Diabetes Screening in the U.S., 2005–2010
Casagrande, S. S., Cowie, C. C., & GENUTH, S. M. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.07.039 · Cited by 33
Vascular memory: can we broaden the concept of the metabolic memory?
Jermendy, G. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-44 · Cited by 36
Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases
Huang, W., Chen, Y., Li, Z., He, F., & Zhang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810882 · Cited by 33
Data analytics identify glycated haemoglobin co-markers for type 2 diabetes mellitus diagnosis
Jelinek, H. F., Stranieri, A., Yatsko, A., & Venkatraman, S. (2016) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2016.05.005 · Cited by 32
Pathways of Prevention: A Scoping Review of Dietary and Exercise Interventions for Neurocognition
Smith, P. J. (2019) · Brain Plasticity · doi:10.3233/bpl-190083 · Cited by 35
Olivarius, N. D. F., Siersma, V., Køster‐Rasmussen, R., Heitmann, B. L., & Waldorff, F. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122219 · Cited by 34
Gæde, P., Johansen, P., Tikkanen, C. K., Pollock, R. F., Hunt, B., & Malkin, S. J. P. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0630-6 · Cited by 32
Effects of coenzyme Q10 intervention on diabetic kidney disease
Zhang, X., Shi, Z., Liu, Q., Quan, H., & Cheng, X. (2019) · Medicine · doi:10.1097/md.0000000000015850 · Cited by 32
Tang, E. H. M., Mak, I. L., Tse, E. T. Y., Wan, E. Y. F., Yu, E. Y. T., Chen, J. Y., Chin, W. Y., Chao, D. V. K., Tsui, W. W. S., Ha, T. K. H., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0387 · Cited by 31
Tao, L., Wilson, E., Griffin, S. J., & Simmons, R. K. (2013) · Value in Health · doi:10.1016/j.jval.2013.06.001 · Cited by 31
Self-citationPérez, A., Raya, P. M., de Arellano, A. R., Briones, T., Hunt, B., & Valentine, W. J. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0103-5 · Cited by 30
Khunti, K. K., Morris, D. H., Weston, C. L., Gray, L. J., Webb, D. R., & Davies, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055580 · Cited by 30
Self-citationSortsø, C., Komkova, A., Sandbæk, A., Griffin, S. J., Emneus, M., Lauritzen, T., & Simmons, R. K. (2018) · Diabetologia · doi:10.1007/s00125-018-4594-2 · Cited by 30
Self-citationMäättä, L. L., Charles, M., Witte, D. R., Bjerg, L., Jørgensen, M. E., Jensen, T. S., & Andersen, S. T. (2019) · Diabetes Care · doi:10.2337/dc19-0869 · Cited by 31
Rahman, M., Simmons, R. K., Hennings, S., Wareham, N. J., & Griffin, S. J. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03570.x · Cited by 32
Self-citationKoekkoek, P. S., Rutten, G. E. H. M., van den Berg, E., van Sonsbeek, S., Gorter, K. J., Kappelle, L. J., & Biessels, G. J. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.02.028 · Cited by 29
Self-citationIntensified Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus
Sasako, T., Yamauchi, T., & Ueki, K. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0325 · Cited by 32
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018
Cuixart, C. B., Sánchez, J. J. A., Banegas, J. R., León, C. F., Lobos-Bejarano, J. M., Rioboó, E. M., Pérez, J. N., Orozco‐Beltrán, D., & Álvarez, F. V. (2018) · Atención Primaria · doi:10.1016/s0212-6567(18)30360-3 · Cited by 29
Johansen, N. B., Charles, M., Vistisen, D., Rasmussen, S. S., Wiinberg, N., Borch‐Johnsen, K., Lauritzen, T., Sandbæk, A., & Witte, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0176 · Cited by 28
Self-citationden Ouden, H., Vos, R. C., & Rutten, G. E. H. M. (2017) · Health Expectations · doi:10.1111/hex.12563 · Cited by 28
Self-citationMitochondrial aldehyde dehydrogenase 2 activation and cardioprotection
Gong, D., Zhang, H., & Hu, S. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.017 · Cited by 28
Sinha, B., & Ghosal, S. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01062-6 · Cited by 33
Stankevič, E., Kern, T., Borisevich, D., Poulsen, C. S., Madsen, A. L., Hansen, T. H., Jonsson, A. E., Schubert, M., Nygaard, N., Nielsen, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65538-8 · Cited by 28
Samodova, D., Stankevič, E., Søndergaard, M. S., Hu, N., Ahluwalia, T. S., Witte, D. R., Belstrøm, D., Lubberding, A. F., Jagtap, P. D., Hansen, T. F., et al. (2025) · Microbiome · doi:10.1186/s40168-024-01997-5 · Cited by 27
Karagiannis, T., Liakos, A., Branda, M. E., Athanasiadou, E. A., Mainou, M., Boura, P., Goulis, D. G., LeBlanc, A., Montori, V. M., & Τσάπας, Α. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012185 · Cited by 28
A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction
Merino, J., Udler, M. S., Leong, A., & Meigs, J. B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0958-0 · Cited by 28
Prediction of Type 2 Diabetes by Hemoglobin A1c in Two Community-Based Cohorts
Leong, A., Daya, N. R., Porneala, B., Devlin, J. J., Shiffman, D., McPhaul, M. J., Selvin, E., & Meigs, J. B. (2017) · Diabetes Care · doi:10.2337/dc17-0607 · Cited by 28
Salinero-Fort, M. Á., de Burgos‐Lunar, C., Prieto, J. M. M., Lahoz, C., Abánades-Herranz, J. C., Gómez‐Campelo, P., Cuesta, F. L., de Cabo, E. E., García-Iglesias, F., González-Alegre, T., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007195 · Cited by 29
Myocardial dysfunction and cardiovascular disease in type 2 diabetes
Ofstad, A. P. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2016.1155230 · Cited by 25
A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs.
Grass, G. M., & Lee, V. H. (1993) · PubMed · Cited by 25
Eskandari, S., Sajadimajd, S., Alaei, L., Soheilikhah, Z., Derakhshankhah, H., & Bahrami, G. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00381-7 · Cited by 24
Effect of an Educational Toolkit on Quality of Care: A Pragmatic Cluster Randomized Trial
Shah, B. R., Bhattacharyya, O. K., Yu, C. H. Y., Mamdani, M., Parsons, J. A., Straus, S. E., & Zwarenstein, M. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001588 · Cited by 24
den Ouden, H., Vos, R. C., Reidsma, C., & Rutten, G. E. H. M. (2015) · BMC Family Practice · doi:10.1186/s12875-015-0230-0 · Cited by 24
Self-citationWho Should We Target for Diabetes Prevention and Diabetes Risk Reduction?
Blüher, S., Markert, J., Herget, S., Yates, T. E., Davis, M. J., Müller, G., Waldow, T., & Schwarz, P. E. H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0255-x · Cited by 24
Bjerggaard, M., Charles, M., Kristensen, E., Lauritzen, T., Sandbæk, A., & Giraldi, A. G. E. (2015) · Sexual Medicine · doi:10.1002/sm2.91 · Cited by 24
Self-citationLau, C. J., Pisinger, C. H., Husemoen, L. L. N., Jacobsen, R. K., Linneberg, A. R., Jørgensen, T., & Glümer, C. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.016 · Cited by 24
Echouffo-Tcheugui, J. B., Simmons, R. K., Prevost, A. T., Williams, K. M., Kinmonth, A. L., Wareham, N. J., & Griffin, S. J. (2015) · The Annals of Family Medicine · doi:10.1370/afm.1737 · Cited by 24
Self-citationChatziralli, I., Sergentanis, T. Ν., Crosby‐Nwaobi, R., Winkley, K., Eleftheriadis, H., Ismail, K., Amiel, S. A., & Sivaprasad, S. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21713 · Cited by 26
Vaccaro, O., Franzini, L., Miccoli, R., Cavalot, F. L., Ardigò, D., Boemi, M., Feo, P. D., Reboldi, G., Rivellese, A. A., Trovati, M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1781 · Cited by 23
Mortensen, M. B., Kulenovic, I., & Falk, E. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0400-y · Cited by 23
Ayadurai, S., Hattingh, L., Tee, L. B. G., & Said, S. N. M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5897452 · Cited by 23
Davies, M. J., Gray, L. J., Ahrabian, D., Carey, M., Farooqi, A., Gray, A. M., Goldby, S., Hill, S., Jones, K. L., Leal, J., et al. (2017) · Programme Grants for Applied Research · doi:10.3310/pgfar05020 · Cited by 26
Self-citationSanz, J., Moreno, P., & Fuster, V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.045 · Cited by 22
Simmons, R., Sharp, S., Sandbaek, A., Borch-Johnsen, K., Davies, M., Khunti, K., Lauritzen, T., Rutten, G., van den Donk, M., Wareham, N., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03759.x · Cited by 23
Self-citationPeckham, S., Falconer, J., Gillam, S., Hann, A., Kendall, S. A., Nanchahal, K., Ritchie, B., Rogers, R. L., & Wallace, A. (2015) · Health Services and Delivery Research · doi:10.3310/hsdr03290 · Cited by 23
Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care
Frei, A. L., Herzog, S., Woitzek, K., Held, U., Senn, O., Rosemann, T. J., & Chmiel, C. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-70 · Cited by 22
Sattar, N. A., & Preiss, D. (2012) · Diabetologia · doi:10.1007/s00125-012-2510-8 · Cited by 22
Exercise Interventions to Prevent and Manage Type 2 Diabetes: Physiological Mechanisms
Dela, F., Prats, C., & Helge, J. W. (2014) · Medicine and sport science/Medicine and sport · doi:10.1159/000357334 · Cited by 24
Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study
Kojima, Y. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i1.8 · Cited by 21
Jørgensen, M. E., & Faurholt‐Jepsen, D. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0505-1 · Cited by 21
The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and Validation
Ye, W., Brändle, M., Brown, M. B., & Herman, W. H. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0304 · Cited by 21
Tao, L., Wilson, E., Wareham, N. J., Sandbæk, A., Rutten, G. E. H. M., Lauritzen, T., Khunti, K., Davies, M. J., Borch‐Johnsen, K., Griffin, S. J., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12711 · Cited by 21
Self-citationPredictors of undiagnosed prevalent type 2 diabetes – The Danish General Suburban Population Study
Heltberg, A., Andersen, J. S., Sandholdt, H., Siersma, V., Kragstrup, J., & Ellervik, C. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.08.005 · Cited by 22
Malkin, S. J. P., Russel-Szymczyk, M., Liidemann, G., Volke, V., & Hunt, B. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0542-x · Cited by 21
Albu, J., Sohler, N., Li, R., Li, X., Young, E., Gregg, E. W., & Ross‐Degnan, D. (2017) · Diabetes Care · doi:10.2337/dc16-2133 · Cited by 21
van den Donk, M., Griffin, S. J., Stellato, R. K., Simmons, R. K., Sandbæk, A., Lauritzen, T., Khunti, K. K., Davies, M. J., Borch‐Johnsen, K., Wareham, N. J., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3011-0 · Cited by 20
Self-citationMilligan, S. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.03.010 · Cited by 20
Should we screen for type 2 diabetes among asymptomatic individuals? Yes
Simmons, D. S., & Zgibor, J. C. (2017) · Diabetologia · doi:10.1007/s00125-017-4397-x · Cited by 20
Should we screen for type 2 diabetes: Yes
Khunti, K. K., & Davies, M. J. (2012) · BMJ · doi:10.1136/bmj.e4514 · Cited by 20
Self-citationBlack, J. A., Sharp, S., Wareham, N., Sandbaek, A., Rutten, G., Lauritzen, T., Khunti, K., Davies, M. J., Borch-Johnsen, K., Griffin, S., et al. (2014) · Diabetic Medicine · doi:10.1111/dme.12410 · Cited by 23
Self-citationMartínez, J. J. G., Malkin, S. J. P., Martín, V., Hallén, N., & Hunt, B. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1681436 · Cited by 22
Schulze, M. B., & Hu, F. B. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_66 · Cited by 20
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020
Orozco‐Beltrán, D., Cuixart, C. B., Sánchez, J. J. A., Banegas, J. R., Cuenca, A. M. C., Gil-Guillén, V. F., Rioboó, E. M., & Pérez, J. N. (2020) · Atención Primaria · doi:10.1016/j.aprim.2020.08.002 · Cited by 24
Metadata
- Authors
- Griffin, S. J., Borch-Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E., Sandbæk, A., Sharp, S. J., Simmons, R. K., van den Donk, M., Wareham, N. J., & Lauritzen, T.
- Affiliations
- University of Cambridge (GB)
- University of Leicester (GB)
- University Medical Center Utrecht (NL)
- Aarhus University (DK)
- Wellcome/MRC Institute of Metabolic Science (GB)
- Corresponding author
- Griffin, Simon J
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 378
- Issue
- 9786
- Pages
- 156-167
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC3136726
- OpenAlex
- W2146392529
- Cited by
- 462
- References
- 43
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 17 · 2023: 14 · 2022: 21 · 2021: 18 · 2020: 35 · 2019: 31 · 2018: 30 · 2017: 38 · 2016: 30 · 2015: 49 · 2014: 46 · 2013: 46 · 2012: 56
- FWCI
- 50.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Funders
- the Wellcome Trust (G061895)
- the Medical Research Council (G0001164)
- the NIHR Health Technology Assessment Programme (08/116/300)
- National Health Service R&D support funding (RP-PG-0606-1259)
- Department of Health and ad hoc Support Sciences, the NIHR Health Technology Assessment Programme (08/116/300)
- the Department of Health NIHR Programme Grant funding scheme (RP-PG-0606-1272)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, cardiovascular risk management, diabetes screening, cardiovascular events, cardiovascular mortality, all-cause mortality, revascularization, non-traumatic amputation, HbA1c, blood pressure, cholesterol, general practice, primary prevention, secondary prevention, risk stratification
- MeSH terms
- Aged, Denmark, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Mass Screening, Middle Aged, Netherlands, Risk Factors, Cluster Analysis, Outcome Assessment, Health Care, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
